| UniProt ID | PAR10_HUMAN | |
|---|---|---|
| UniProt AC | Q53GL7 | |
| Protein Name | Poly [ADP-ribose] polymerase 10 | |
| Gene Name | PARP10 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1025 | |
| Subcellular Localization | Nucleus, nucleolus . Cytoplasm . Shuttles between the nuclear and cytoplasmic compartment. A subpopulation concentrates in the nucleolus during late G1/S phase. | |
| Protein Description | May play a role in cell proliferation. May be required for the maintenance of cell cycle progression.. | |
| Protein Sequence | MVAMAEAEAGVAVEVRGLPPAVPDELLTLYFENRRRSGGGPVLSWQRLGCGGVLTFREPADAERVLAQADHELHGAQLSLRPAPPRAPARLLLQGLPPGTTPQRLEQHVQALLRASGLPVQPCCALASPRPDRALVQLPKPLSEADVRVLEEQAQNLGLEGTLVSLARVPQARAVRVVGDGASVDLLLLELYLENERRSGGGPLEDLQRLPGPLGTVASFQQWQVAERVLQQEHRLQGSELSLVPHYDILEPEELAENTSGGDHPSTQGPRATKHALLRTGGLVTALQGAGTVTMGSGEEPGQSGASLRTGPMVQGRGIMTTGSGQEPGQSGTSLRTGPMGSLGQAEQVSSMPMGSLEHEGLVSLRPVGLQEQEGPMSLGPVGSAGPVETSKGLLGQEGLVEIAMDSPEQEGLVGPMEITMGSLEKAGPVSPGCVKLAGQEGLVEMVLLMEPGAMRFLQLYHEDLLAGLGDVALLPLEGPDMTGFRLCGAQASCQAAEEFLRSLLGSISCHVLCLEHPGSARFLLGPEGQHLLQGLEAQFQCVFGTERLATATLDTGLEEVDPTEALPVLPGNAHTLWTPDSTGGDQEDVSLEEVRELLATLEGLDLDGEDWLPRELEEEGPQEQPEEEVTPGHEEEEPVAPSTVAPRWLEEEAALQLALHRSLEPQGQVAEQEEAAALRQALTLSLLEQPPLEAEEPPDGGTDGKAQLVVHSAFEQDVEELDRALRAALEVHVQEETVGPWRRTLPAELRARLERCHGVSVALRGDCTILRGFGAHPARAARHLVALLAGPWDQSLAFPLAASGPTLAGQTLKGPWNNLERLAENTGEFQEVVRAFYDTLDAARSSIRVVRVERVSHPLLQQQYELYRERLLQRCERRPVEQVLYHGTTAPAVPDICAHGFNRSFCGRNATVYGKGVYFARRASLSVQDRYSPPNADGHKAVFVARVLTGDYGQGRRGLRAPPLRGPGHVLLRYDSAVDCICQPSIFVIFHDTQALPTHLITCEHVPRASPDDPSGLPGRSPDT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 37 | Phosphorylation | YFENRRRSGGGPVLS EECCCCCCCCCCCCC | 39.72 | 30108239 | |
| 44 | Phosphorylation | SGGGPVLSWQRLGCG CCCCCCCCEEECCCC | 22.77 | - | |
| 79 | Phosphorylation | ELHGAQLSLRPAPPR HHHCCEEECCCCCCC | 15.39 | 24719451 | |
| 101 | Phosphorylation | QGLPPGTTPQRLEQH CCCCCCCCHHHHHHH | 24.28 | 22817900 | |
| 106 | ADP-ribosylation | GTTPQRLEQHVQALL CCCHHHHHHHHHHHH | 40.61 | 25043379 | |
| 128 | Phosphorylation | QPCCALASPRPDRAL CCCEECCCCCCCCEE | 23.45 | 27251275 | |
| 140 | ADP-ribosylation | RALVQLPKPLSEADV CEEECCCCCCCHHHH | 68.15 | 25043379 | |
| 140 | Ubiquitination | RALVQLPKPLSEADV CEEECCCCCCCHHHH | 68.15 | - | |
| 143 | Phosphorylation | VQLPKPLSEADVRVL ECCCCCCCHHHHHHH | 38.99 | 28348404 | |
| 199 | Phosphorylation | YLENERRSGGGPLED HHHCCCCCCCCCHHH | 48.27 | 20071362 | |
| 274 | Ubiquitination | TQGPRATKHALLRTG CCCCHHHHCHHHHHC | 26.37 | - | |
| 304 | Phosphorylation | SGEEPGQSGASLRTG CCCCCCCCCCCCCCC | 42.09 | 27251275 | |
| 307 | Phosphorylation | EPGQSGASLRTGPMV CCCCCCCCCCCCCCC | 23.16 | 27251275 | |
| 310 | Phosphorylation | QSGASLRTGPMVQGR CCCCCCCCCCCCCCC | 51.43 | 20068231 | |
| 321 | Phosphorylation | VQGRGIMTTGSGQEP CCCCCEEECCCCCCC | 26.53 | 20068231 | |
| 322 | Phosphorylation | QGRGIMTTGSGQEPG CCCCEEECCCCCCCC | 16.39 | 20068231 | |
| 324 | Phosphorylation | RGIMTTGSGQEPGQS CCEEECCCCCCCCCC | 34.90 | 20068231 | |
| 331 | Phosphorylation | SGQEPGQSGTSLRTG CCCCCCCCCCCCCCC | 50.37 | 20068231 | |
| 333 | Phosphorylation | QEPGQSGTSLRTGPM CCCCCCCCCCCCCCC | 29.81 | 20068231 | |
| 334 | Phosphorylation | EPGQSGTSLRTGPMG CCCCCCCCCCCCCCC | 21.27 | 28857561 | |
| 337 | Phosphorylation | QSGTSLRTGPMGSLG CCCCCCCCCCCCCCC | 51.43 | 24043423 | |
| 342 | Phosphorylation | LRTGPMGSLGQAEQV CCCCCCCCCCCHHHC | 24.07 | 24043423 | |
| 342 | O-linked_Glycosylation | LRTGPMGSLGQAEQV CCCCCCCCCCCHHHC | 24.07 | 29351928 | |
| 350 | Phosphorylation | LGQAEQVSSMPMGSL CCCHHHCCCCCCCCC | 22.18 | 24043423 | |
| 351 | Phosphorylation | GQAEQVSSMPMGSLE CCHHHCCCCCCCCCC | 28.22 | 24043423 | |
| 356 | Phosphorylation | VSSMPMGSLEHEGLV CCCCCCCCCCCCCCE | 25.08 | 24043423 | |
| 356 | O-linked_Glycosylation | VSSMPMGSLEHEGLV CCCCCCCCCCCCCCE | 25.08 | 29351928 | |
| 364 | Phosphorylation | LEHEGLVSLRPVGLQ CCCCCCEEEEECCCC | 24.57 | 24719451 | |
| 378 | Phosphorylation | QEQEGPMSLGPVGSA CCCCCCCCCCCCCCC | 33.05 | 27251275 | |
| 407 | Phosphorylation | LVEIAMDSPEQEGLV CEEEECCCHHHCCCC | 19.77 | 27251275 | |
| 420 | Phosphorylation | LVGPMEITMGSLEKA CCCCEEEEECCHHHC | 11.37 | 24275569 | |
| 423 | Phosphorylation | PMEITMGSLEKAGPV CEEEEECCHHHCCCC | 23.64 | 27251275 | |
| 431 | Phosphorylation | LEKAGPVSPGCVKLA HHHCCCCCCCCHHCC | 20.78 | 23401153 | |
| 601 | Phosphorylation | EVRELLATLEGLDLD HHHHHHHHHHCCCCC | 25.88 | - | |
| 663 | Phosphorylation | LQLALHRSLEPQGQV HHHHHHHHCCCCCCH | 26.74 | 26657352 | |
| 882 | ADP-ribosylation | RCERRPVEQVLYHGT HHHHCCHHHHEECCC | 37.34 | 18851833 | |
| 916 | Ubiquitination | RNATVYGKGVYFARR CCCEEECCCEEEEEE | 27.76 | 19608861 | |
| 916 | Acetylation | RNATVYGKGVYFARR CCCEEECCCEEEEEE | 27.76 | 19608861 | |
| 916 | ADP-ribosylation | RNATVYGKGVYFARR CCCEEECCCEEEEEE | 27.76 | 25043379 | |
| 925 | Phosphorylation | VYFARRASLSVQDRY EEEEEEEECCCCCCC | 21.26 | 23401153 | |
| 927 | Phosphorylation | FARRASLSVQDRYSP EEEEEECCCCCCCCC | 18.42 | 30108239 | |
| 928 | Ubiquitination | ARRASLSVQDRYSPP EEEEECCCCCCCCCC | 9.23 | 21890473 | |
| 928 | Ubiquitination | ARRASLSVQDRYSPP EEEEECCCCCCCCCC | 9.23 | 21890473 | |
| 941 | Ubiquitination | PPNADGHKAVFVARV CCCCCCCCEEEEEEE | 52.34 | - | |
| 953 | Phosphorylation | ARVLTGDYGQGRRGL EEEHHCCCCCCCCCC | 16.82 | 23285258 | |
| 986 | Phosphorylation | VDCICQPSIFVIFHD HCCEECCEEEEEEEC | 11.63 | 28348404 | |
| 1011 | Phosphorylation | CEHVPRASPDDPSGL EECCCCCCCCCCCCC | 30.09 | 30266825 | |
| 1016 | Phosphorylation | RASPDDPSGLPGRSP CCCCCCCCCCCCCCC | 61.02 | 30266825 | |
| 1022 | Phosphorylation | PSGLPGRSPDT---- CCCCCCCCCCC---- | 32.80 | 30266825 | |
| 1025 | Phosphorylation | LPGRSPDT------- CCCCCCCC------- | 43.84 | 30266825 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PAR10_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAR10_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MYC_HUMAN | MYC | physical | 15674325 | |
| H31_HUMAN | HIST1H3A | physical | 15674325 | |
| H2A2C_HUMAN | HIST2H2AC | physical | 15674325 | |
| H2B2E_HUMAN | HIST2H2BE | physical | 15674325 | |
| MYC_HUMAN | MYC | physical | 22992334 | |
| SQSTM_HUMAN | SQSTM1 | physical | 22992334 | |
| NEMO_HUMAN | IKBKG | physical | 23575687 | |
| PCNA_HUMAN | PCNA | physical | 24695737 | |
| UBC_HUMAN | UBC | physical | 23575687 | |
| PAR14_MOUSE | Parp14 | physical | 23473667 | |
| RAN_HUMAN | RAN | physical | 23473667 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-916, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "CDK-dependent activation of poly(ADP-ribose) polymerase member 10(PARP10)."; Chou H.Y., Chou H.T., Lee S.C.; J. Biol. Chem. 281:15201-15207(2006). Cited for: FUNCTION, AND PHOSPHORYLATION AT THR-101. | |